Initiation of a Phase I/IIa first-in-human trial for GLIX1 in glioblastoma (GBM) was announced, with the first patient dosed at NYU Langone Health; two additional academic centers (Northwestern ...

NOW Inc. (NYSE:DNOW) Q4 2024 Earnings Call Transcript February 13, 2025 NOW Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.14. Operator: Good morning. My name is John, ...

Q1 2027 Earnings Call May 28, 2026 9:00 AM EDTCompany ParticipantsTrevor Novotny - Director of Investor RelationsMichael Bender ...

Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market PositionUrges Stockholders to Vote ...

Thanks for joining us today for our first quarter 2026 earnings call. In the first quarter, against the backdrop of ...

Staking drove 60% of disclosed revenue at publicly listed ETH treasury firms in 2025. ETH treasury firms booked $1.41 billion in combined FY2025 losses. BitMine alone posted a $9.02 billion net loss ...

Company Highlights Record-Breaking Financial Performance as Successful Business Transformation has Created Historic Value for ...

Completed repurchase of $1.5 billion aggregate principal amount of 2029 Notes for approximately $1.38 billion in cash, an approximate 8% discount to par Through the debt repurchase, generated BTC ...

Service segment revenue -- 29% growth, with organic growth at 7%; remainder attributable to Martin Calibration and Essco ...

Claire Boyte-White is the lead writer for NapkinFinance.com, co-author of I Am Net Worthy, and an Investopedia contributor. Claire's expertise lies in corporate finance & accounting, mutual funds, ...

Discover how cash flow from operating activities reveals a company's core business cash-generating efficiency, using both ...